Skip to content
OpenCapital
Get started

Medtronic MDT Diabetes — Other segment items

Other segment segments

Neuroscience
$13M+8.3%
Medical Surgical
$5M+25.0%
Cardiovascular
-$1M+92.9%

Similar metrics at other companies

AdaptHealth logo
AHCODiabetes Health — Other segment item
$14.47M+6.7%
AdaptHealth logo
AHCODiabetes Health — Other operating expenses
$2.13M+14.9%
Opko Health logo
OPKDiagnostics — Segment Reporting Other Item Amount
-$18.07M—
Healthcare Services Group logo
HCSGDietary — Other segment items
$5.8M-4.6%
Danaher logo
DHRDiagnostics — Segment Reporting, Other Segment Item, Amount
$1.86B+15.9%
Baxter International logo
BAXHealthcare Systems & Technologies — Other segment items
-$9M-28.6%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$109.71B-5.1%
Enterprise value$136.97B-4.2%
P/E22.9×-2.0×
P/S3×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's diabetes — other segment items.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's diabetes — other segment items?
Medtronic (MDT) reported diabetes — other segment items of -$2M in Q4 2025.
How has Medtronic's diabetes — other segment items changed year-over-year?
Medtronic's diabetes — other segment items increased by 86.7% year-over-year, from -$15M to -$2M.
What is the long-term trend for Medtronic's diabetes — other segment items?
Over 2 years (2023 to 2025), Medtronic's diabetes — other segment items has grown at a -30.9% compound annual growth rate (CAGR), from -$90M to -$43M.
What does diabetes — other segment items mean?
This represents miscellaneous income or expenses specific to the diabetes segment that do not fit into standard categories like R&D or SG&A. It may include restructuring charges, legal settlements, or gains/losses on asset disposals. It is used to reconcile the segment's operating profit to its core operational performance.